Cite
APA Citation
Jeannot, V., Busser, B., Brambilla, E., Wislez, M., Robin, B., Cadranel, J., Coll, J., & Hurbin, A. (n.d.). the PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism. International journal of cancer, 134(11), 2560–2571. http://access.bl.uk/ark:/81055/vdc_100024767942.0x000055